PT Darya-Varia Laboratoria Tbk (“Darya-Varia” or “the Company”) is a domestic investment pharmaceutical company established in 1976. In November 1994, Darya-Varia listed its shares on the Indonesia Stock Exchange (IDX) with the stock ticker code of DVLA.
In 1995, Darya-Varia acquired PT Pradja Pharin (Prafa) and became the parent entity to continue expanding into the health sector in Indonesia. In 2014, the Company merged with Prafa, with Darya-Varia as the sole surviving entity.
Currently, Darya-Varia operates two manufacturing plants that have met the international standards of current Good Manufacturing Practice (c-GMP) and standards set by the National Agency of Drug and Food Control (BPOM).
Soft gelatin capsule products, liquid preparations, medicinal plasters, ointments, and creams are produced at the Gunung Putri Plant. In producing these products, Gunung Putri Plant implements an Integrated Management System and has obtained ISO 9001:2015, ISO 14001:2015, ISO 45001:2018 and ISO 22000:2018 certificates.
Meanwhile, sterile injection products and solid preparations in the form of tablets and capsules are produced at the Citeureup Plant. The Citeureup Plant also implements an Integrated Management System and has obtained ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, and SNI ISO/IEC 17025:2017 certificates.
In running the Toll Manufacturing business, Darya-Varia collaborates with an affiliated company, PT Medifarma Laboratories, at the Cimanggis Depok Plant. The Company has been trusted by local business partners and both for the domestic and international markets for the Export & Toll Manufacturing business and conducts technology transfer, lab and pilot trials, stability studies, procurement of raw materials and packaging, and commercial production of high-quality finished goods.
Darya-Varia always ensures the quality and safety of each product, so that all of its products are certified halal. All plant facilities owned by Darya-Varia have implemented the halal guarantee system.
Blue Sphere Singapore Pte Ltd (BSSPL) owns 92.13% stake in Darya-Varia. For 46 years, Darya-Varia has continued to progress in providing high quality health facilities. Through the mission of “building a healthier Indonesia for everyone one person at a time”, Darya-Varia is always committed to providing a variety of quality products with the right strategy for the health of the Indonesian people.